Ausgabe 2/2023
Histones and Histone Modifiers in Tumor Progression and Metastasis
Inhalt (14 Artikel)
Editorial
Epigenetic changes and the dynamic heterogeneity of the metastatic phenotype – challenges ahead
Danny R. Welch
Oncohistones and disrupted development in pediatric-type diffuse high-grade glioma
Jennifer K. Ocasio, Kaitlin M. Budd, Jordan T. Roach, Jared M. Andrews, Suzanne J. Baker
Pancreatic cancer epigenetics: adaptive metabolism reprograms starving primary tumors for widespread metastatic outgrowth
Arnaldo J. Franco Torres, Jeffrey Duryea, Oliver G. McDonald
Open Access
Oncogenic signaling-mediated regulation of chromatin during tumorigenesis
Jahangir Alam, Md Nazmul Huda, Alan J Tackett, Sayem Miah
Epigenetic markers and therapeutic targets for metastasis
Carolyn J. Kravitz, Qin Yan, Don X. Nguyen
The role of histone H3 lysine demethylases in glioblastoma
Dejauwne Young, Chandan Guha, Simone Sidoli
Open Access
(mis)-Targeting of SWI/SNF complex(es) in cancer
Divya Reddy, Saikat Bhattacharya, Jerry L. Workman
Open Access
CLINICAL
Combination of immune-checkpoint inhibitors and targeted therapies for melanoma therapy: The more, the better?
Maximilian Haist, Henner Stege, Michael Kuske, Julia Bauer, Annika Klumpp, Stephan Grabbe, Matthias Bros
Open Access
NON-THEMATIC REVIEW
Considerations for modelling diffuse high-grade gliomas and developing clinically relevant therapies
Sarah L. Higginbottom, Eva Tomaskovic-Crook, Jeremy M. Crook
Open Access
NON-THEMATIC REVIEW
The tumor-nerve circuit in breast cancer
Qiuxia Cui, Dewei Jiang, Yuanqi Zhang, Ceshi Chen
Non-Thematic Review
Colorectal cancer liver metastasis: genomic evolution and crosstalk with the liver microenvironment
Qiu-Luo Liu, Huijie Zhou, Zong-Guang Zhou, Hai-Ning Chen